Publication Date:
2011-08-13
Description:
Pyrazinamide (PZA) is a first-line tuberculosis drug that plays a unique role in shortening the duration of tuberculosis chemotherapy. PZA is hydrolyzed intracellularly to pyrazinoic acid (POA) by pyrazinamidase (PZase, encoded by pncA), an enzyme frequently lost in PZA-resistant strains, but the target of POA in Mycobacterium tuberculosis has remained elusive. Here, we identify a previously unknown target of POA as the ribosomal protein S1 (RpsA), a vital protein involved in protein translation and the ribosome-sparing process of trans-translation. Three PZA-resistant clinical isolates without pncA mutation harbored RpsA mutations. RpsA overexpression conferred increased PZA resistance, and we confirmed that POA bound to RpsA (but not a clinically identified DeltaAla mutant) and subsequently inhibited trans-translation rather than canonical translation. Trans-translation is essential for freeing scarce ribosomes in nonreplicating organisms, and its inhibition may explain the ability of PZA to eradicate persisting organisms.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502614/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉 〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502614/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Shi, Wanliang -- Zhang, Xuelian -- Jiang, Xin -- Yuan, Haiming -- Lee, Jong Seok -- Barry, Clifton E 3rd -- Wang, Honghai -- Zhang, Wenhong -- Zhang, Ying -- AI44063/AI/NIAID NIH HHS/ -- ZIA AI000783-16/Intramural NIH HHS/ -- New York, N.Y. -- Science. 2011 Sep 16;333(6049):1630-2. doi: 10.1126/science.1208813. Epub 2011 Aug 11.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/21835980" target="_blank"〉PubMed〈/a〉
Keywords:
Amidohydrolases/genetics/metabolism
;
Amino Acid Sequence
;
Antitubercular Agents/metabolism/*pharmacology
;
Bacterial Proteins/chemistry/genetics/*metabolism
;
Drug Resistance, Bacterial
;
Molecular Sequence Data
;
Mutant Proteins/metabolism
;
Mutation
;
Mycobacterium tuberculosis/*drug effects/genetics/metabolism
;
Prodrugs/metabolism/pharmacology
;
Protein Binding
;
Protein Biosynthesis/drug effects
;
Protein Structure, Tertiary
;
Pyrazinamide/*analogs & derivatives/metabolism/*pharmacology
;
RNA, Bacterial/metabolism
;
RNA, Messenger/metabolism
;
RNA, Transfer/metabolism
;
Ribosomal Proteins/chemistry/genetics/*metabolism
;
Ribosomes/metabolism
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
